A Review of Complementary and Alternative Approaches to Immunomodulation.

Current Western therapies for inflammatory diseases are suboptimal; increasingly, patients are turning to complementary and alternative medicine for symptom relief and improved quality of life. There is emerging evidence that many of these therapies have the ability to modulate the immune system and disrupt the proinflammatory cascade through a variety of mechanisms, including antioxidant effects, alterations in cell signaling (in particular the nuclear factor (NF)-κB pathway), cytokines, proinflammatory mediators, and disruption of bacterial flora. Using inflammatory bowel disease (IBD) as a model of inflammation, we explore the principal complementary and alternative medicine treatments that show promise in this regard, namely, resveratrol, green tea, curcumin, boswellia, fish oil, vitamin D, and probiotics. With each agent, we detail the mechanisms that have been described with regard to immune modulation, discuss the medical conditions for which it has been evaluated, and explore the data to date for the prevention or treatment of IBD.

[1]  L. Kopelovich,et al.  Resveratrol: a review of preclinical studies for human cancer prevention. , 2007, Toxicology and applied pharmacology.

[2]  B. Hyman,et al.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.

[3]  A. Dobs,et al.  Vitamin d and its role in cancer and immunity: a prescription for sunlight. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[4]  Liz Y. Han,et al.  Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway , 2007, Clinical Cancer Research.

[5]  N. Nieto Ethanol and fish oil induce NFκB transactivation of the collagen α2(I) promoter through lipid peroxidation–driven activation of the PKC‐PI3K‐Akt pathway , 2007 .

[6]  P. Calder,et al.  Immune modulation by parenteral lipid emulsions. , 2007, The American journal of clinical nutrition.

[7]  J. Buckley,et al.  Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. , 2007, The American journal of clinical nutrition.

[8]  R. Goldberg,et al.  A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain , 2007, Pain.

[9]  O. Inatomi,et al.  Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis , 2007, Digestive Diseases and Sciences.

[10]  M. Cantorna,et al.  Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury , 2007, BMC Immunology.

[11]  H. Bays Safety considerations with omega-3 fatty acid therapy. , 2007, The American journal of cardiology.

[12]  N. Maulik,et al.  Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. , 2007, Journal of Molecular and Cellular Cardiology.

[13]  F. Shanahan,et al.  Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.

[14]  A. Bonanomi,et al.  The Vitamin D analogue TX 527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  Jennifer L Jones,et al.  The Role of Probiotics in Inflammatory Bowel Disease , 2007, Digestive Diseases and Sciences.

[16]  Bharat B. Aggarwal,et al.  “Spicing Up” of the Immune System by Curcumin , 2007, Journal of Clinical Immunology.

[17]  C. Tartaglia,et al.  Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical. , 2007, World journal of gastroenterology.

[18]  M. Sata,et al.  Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  C. Gordon,et al.  Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease , 2006, Inflammatory bowel diseases.

[20]  O. Werz,et al.  Boswellic acids: biological actions and molecular targets. , 2006, Current medicinal chemistry.

[21]  Irfan Rahman,et al.  Regulation of inflammation and redox signaling by dietary polyphenols. , 2006, Biochemical pharmacology.

[22]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[23]  A. Steinmeyer,et al.  The New Low Calcemic Vitamin D Analog 22-Ene-25-Oxa-Vitamin D Prominently Ameliorates T Helper Cell Type 1-Mediated Colitis in Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  J. Milner,et al.  Diet and Cancer: Facts and Controversies , 2006, Nutrition and cancer.

[25]  R. Providência Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. , 2006, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[26]  A. Simopoulos Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  C. Hawkey,et al.  Probiotics for maintenance of remission in Crohn's disease. , 2006, The Cochrane database of systematic reviews.

[28]  L. Dieleman,et al.  Probiotics and prebiotics in chronic inflammatory bowel diseases. , 2006, World journal of gastroenterology.

[29]  H. Ammon Boswellic Acids in Chronic Inflammatory Diseases , 2006, Planta medica.

[30]  Z. Halpern,et al.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis , 2006, Gut.

[31]  Chang-sheng Deng,et al.  Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. , 2006, International immunopharmacology.

[32]  Chang-sheng Deng,et al.  Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. , 2006, World journal of gastroenterology.

[33]  L. Barenghi,et al.  Cardiovascular protective effects of resveratrol. , 2006, Cardiovascular drug reviews.

[34]  N. Senninger,et al.  Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[35]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[36]  T. Buclin,et al.  Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. , 2006, Clinical nutrition.

[37]  Q. Ouyang,et al.  Probiotics and inflammatory bowel diseases , 2006, Postgraduate Medical Journal.

[38]  S. Willich,et al.  Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease , 2006, BMC complementary and alternative medicine.

[39]  T. Mickleborough,et al.  Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. , 2006, Chest.

[40]  Reyes Artacho,et al.  Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.

[41]  W. Hunter,et al.  The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis , 2006, Inflammation Research.

[42]  M. Sánchez-Hidalgo,et al.  The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model , 2006, British journal of pharmacology.

[43]  A. Singh,et al.  Multiple biological activities of curcumin: a short review. , 2006, Life sciences.

[44]  Daniel Normolle,et al.  Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.

[45]  B. Aggarwal,et al.  Acetyl-11-Keto-β-Boswellic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing NF-κB and NF-κB-Regulated Gene Expression1 , 2006, The Journal of Immunology.

[46]  Antonino Cattaneo,et al.  Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate , 2006, Current Biology.

[47]  J. Funk,et al.  Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. , 2006, Journal of natural products.

[48]  D. Rampton,et al.  Review article: complementary and alternative therapies for inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.

[49]  D. Das,et al.  Retracted: Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFκB , 2006 .

[50]  S. Proudman,et al.  Fish oil: what the prescriber needs to know , 2005, Arthritis research & therapy.

[51]  V. Annese,et al.  Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study , 2005 .

[52]  M. Korabiowska,et al.  Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[53]  J. Drewe,et al.  Epigallocatechin-3-gallate Impairs Chemokine Production in Human Colon Epithelial Cell Lines , 2005, Journal of Pharmacology and Experimental Therapeutics.

[54]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[55]  S. Katz,et al.  Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study , 2005, Digestive Diseases and Sciences.

[56]  Namitha,et al.  A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. , 2005, The Indian journal of medical research.

[57]  Thomas J. Sweet,et al.  Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. , 2005, Antiviral research.

[58]  W. Mojica,et al.  Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. , 2005, American Journal of Clinical Nutrition.

[59]  L. Neckers,et al.  Metabolic and Pharmacological Properties of Rutin, a Dietary Quercetin Glycoside, for Treatment of Inflammatory Bowel Disease , 2005, Pharmaceutical Research.

[60]  E. Mazzon,et al.  Green tea polyphenol extract attenuates colon injury induced by experimental colitis , 2005, Free radical research.

[61]  M. Diederich,et al.  Chemopreventive and therapeutic effects of curcumin. , 2005, Cancer letters.

[62]  C. McClain,et al.  Antioxidants as novel therapy in a murine model of colitis. , 2005, The Journal of nutritional biochemistry.

[63]  J. Goldblum,et al.  An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[64]  D. Besselsen,et al.  Effects of Boswellia serrata in mouse models of chemically induced colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[65]  Jide Wang,et al.  Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. , 2005, World journal of gastroenterology.

[66]  Takuji Tanaka,et al.  Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. , 2005, Biochemical pharmacology.

[67]  M. Comalada,et al.  In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐κB pathway , 2005, European journal of immunology.

[68]  S. Walsh,et al.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial , 2005, Gut.

[69]  Yan Zhu,et al.  Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel disease , 2005 .

[70]  J. Crowell,et al.  Resveratrol-associated renal toxicity. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[71]  M. Comalada,et al.  The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression , 2004, British journal of pharmacology.

[72]  Charles N. Serhan,et al.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.

[73]  A. Imaoka,et al.  Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis , 2004, Alimentary pharmacology & therapeutics.

[74]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[75]  C. Ruxton,et al.  The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[76]  Chih-Hsing Wu,et al.  The protective effect of habitual tea consumption on hypertension. , 2004, Archives of internal medicine.

[77]  H. Nagawa,et al.  Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. , 2004, The Journal of allergy and clinical immunology.

[78]  I. Villegas,et al.  Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. , 2004, Biochemical pharmacology.

[79]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[80]  M. Westerterp-Plantenga,et al.  Effects of green tea on weight maintenance after body-weight loss , 2004, British Journal of Nutrition.

[81]  A. Bhardwaj,et al.  Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. , 2004, Journal of nutritional science and vitaminology.

[82]  Liang-Yi Wu,et al.  Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. , 2004, Journal of agricultural and food chemistry.

[83]  Hao Jiang,et al.  Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. , 2003, Biochemical pharmacology.

[84]  J. Schölmerich,et al.  Rationale for Probiotic and Antibiotic Treatment Strategies in Inflammatory Bowel Diseases , 2003, Digestive Diseases.

[85]  Anton Rietveld,et al.  Antioxidant effects of tea: evidence from human clinical trials. , 2003, The Journal of nutrition.

[86]  Malcolm C Pike,et al.  Green tea and risk of breast cancer in Asian Americans , 2003, International journal of cancer.

[87]  Tetsuro Ito,et al.  Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. , 2003, Carcinogenesis.

[88]  Chih-Hsing Wu,et al.  Relationship among habitual tea consumption, percent body fat, and body fat distribution. , 2003, Obesity research.

[89]  J. Hodgson,et al.  Tea intake is inversely related to blood pressure in older women. , 2003, The Journal of nutrition.

[90]  S. Katiyar Skin photoprotection by green tea: antioxidant and immunomodulatory effects. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[91]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[92]  A. Gomez-Muñoz,et al.  Curcumin attenuates DNB-induced murine colitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[93]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .

[94]  T. Borody,et al.  Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy , 2003, Journal of clinical gastroenterology.

[95]  P. Testoni,et al.  A pilot trial of Saccharomyces boulardii in ulcerative colitis , 2003, European journal of gastroenterology & hepatology.

[96]  S. Karmakar,et al.  Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis , 2003, British journal of pharmacology.

[97]  F. Chilton,et al.  Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. , 2003, Clinical therapeutics.

[98]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[99]  Yukio Koide,et al.  Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. , 2002, Gastroenterology.

[100]  M. Polansky,et al.  Tea enhances insulin activity. , 2002, Journal of agricultural and food chemistry.

[101]  J. Zou,et al.  Low dose of resveratrol enhanced immune response of mice. , 2002, Acta pharmacologica Sinica.

[102]  Andy H. Lee,et al.  Tea consumption and ovarian cancer risk: a case-control study in China. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[103]  J. Quiles,et al.  Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[104]  K. Scott,et al.  Fish consumption and self-reported physical and mental health status , 2002, Public Health Nutrition.

[105]  G. Bulliyya Influence of fish consumption on the distribution of serum cholesterol in lipoprotein fractions: comparative study among fish-consuming and non-fish-consuming populations. , 2002, Asia Pacific journal of clinical nutrition.

[106]  A. Zarzuelo,et al.  Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. , 2002, Life sciences.

[107]  Christine D Wu,et al.  Tea as a functional food for oral health. , 2002, Nutrition.

[108]  J. Manson,et al.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.

[109]  R. Belmaker,et al.  Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.

[110]  J. Nóbrega,et al.  Comparison of Heating Extraction Procedures for Al, Ca, Mg, and Mn in Tea Samples , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[111]  K. Roemer,et al.  Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse , 2001, International journal of cancer.

[112]  James A. Hanley,et al.  A Population-Based Case-Control Study of Lung Cancer and Green Tea Consumption among Women Living in Shanghai, China , 2001, Epidemiology.

[113]  G. Ravagnan,et al.  Effects of resveratrol on human immune cell function. , 2001, Life sciences.

[114]  Xiaohua Gao,et al.  Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. , 2001, Biochemical pharmacology.

[115]  C Poole,et al.  Does tea affect cardiovascular disease? A meta-analysis. , 2001, American journal of epidemiology.

[116]  B. Wong,et al.  Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[117]  R. Lüdtke,et al.  Effects of gum resin of Boswellia serrata in patients with chronic colitis. , 2001, Planta medica.

[118]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[119]  Fajun Yang,et al.  Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. , 2001, The Journal of nutrition.

[120]  M. Inoue,et al.  Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. , 2001, Cancer letters.

[121]  Zuo-Feng Zhang,et al.  Protective effect of green tea on the risks of chronic gastritis and stomach cancer , 2001, International journal of cancer.

[122]  N. Senninger,et al.  Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis , 2001, International Journal of Colorectal Disease.

[123]  C. Elmets,et al.  Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. , 2001, Journal of the American Academy of Dermatology.

[124]  W J van der Vijgh,et al.  Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[125]  Weiya Ma,et al.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. , 2000, Carcinogenesis.

[126]  E. Castanas,et al.  Potent inhibitory action of red wine polyphenols on human breast cancer cells , 2000, Journal of cellular biochemistry.

[127]  G. Mullin,et al.  ANTI‐IL12 IMPOSES THE DEATH SENTENCE ON Thl CELLS IN TNBS COLITIS—IS THERE A LIGHT AT THE END OF THE TUNNEL FOR CROHN'S DISEASE? , 2000, Inflammatory bowel diseases.

[128]  A. Takeshita,et al.  Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. , 2000, Annals of epidemiology.

[129]  O. Eremin,et al.  Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study , 2000 .

[130]  H. Ishikawa,et al.  Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. , 2000, Journal of the American College of Nutrition.

[131]  O. Eremin,et al.  Clinical effect on ulcerative colitis with dietary supplementation by ष-3 fatty acids; a double blind, randomised study , 2000 .

[132]  T. Tsujikawa,et al.  Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease? , 2000, Journal of Gastroenterology.

[133]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[134]  A. Hofman,et al.  Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. , 1999, Archives of internal medicine.

[135]  D. Brenner,et al.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.

[136]  B. Rembacken,et al.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial , 1999, The Lancet.

[137]  P. Brigidi,et al.  Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis , 1999, Alimentary pharmacology & therapeutics.

[138]  D. Kelly Nutrition in inflammatory bowel disease , 1999, Current gastroenterology reports.

[139]  V. Steele,et al.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.

[140]  M. Inoue,et al.  Effect of life styles on the risk of subsite-specific gastric cancer in those with and without family history. , 1999, Journal of epidemiology.

[141]  J. Buring,et al.  Coffee and tea intake and the risk of myocardial infarction. , 1999, American journal of epidemiology.

[142]  S. Heys,et al.  Distal procto-colitis, natural cytotoxicity, and essential fatty acids , 1998, American Journal of Gastroenterology.

[143]  M. Stolte,et al.  Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis , 1997, Alimentary pharmacology & therapeutics.

[144]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[145]  K. Ewe,et al.  N-3 fatty acids only delay early relapse of ulcerative colitis in remission , 1996, Digestive Diseases and Sciences.

[146]  A. Zarzuelo,et al.  Effect of quercitrin on acute and chronic experimental colitis in the rat. , 1996, The Journal of pharmacology and experimental therapeutics.

[147]  W. Fleig,et al.  Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial , 1996 .

[148]  M. Campieri,et al.  Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. , 1996, The New England journal of medicine.

[149]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[150]  B. Joe,et al.  Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.

[151]  E. Isolauri,et al.  Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. , 1993, Gastroenterology.

[152]  C. Ainley,et al.  A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis , 1993, Alimentary pharmacology & therapeutics.

[153]  G. Triadafilopoulos,et al.  Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. , 1992, The American journal of gastroenterology.

[154]  C. Smith,et al.  Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. , 1991, Gut.

[155]  H. Ammon,et al.  Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. , 1991, Planta medica.

[156]  M. Garg,et al.  Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. , 1991, Canadian journal of physiology and pharmacology.

[157]  F. Guarner,et al.  Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. , 1990, Gut.

[158]  A. Kornbluth,et al.  Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. , 1990, Journal of clinical gastroenterology.

[159]  T. Strasser,et al.  Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind cross‐over trial , 1989, Journal of internal medicine. Supplement.

[160]  O. P. Sharma Antioxidant activity of curcumin and related compounds. , 1976, Biochemical pharmacology.

[161]  A. Griffiths,et al.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[162]  T. Terano,et al.  Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases , 2007, Lipids.

[163]  M. Amri,et al.  Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. , 2007, Archives of biochemistry and biophysics.

[164]  N. Nieto Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. , 2007, Hepatology.

[165]  J. Sayre,et al.  Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. , 2006, Journal of Alzheimer's disease : JAD.

[166]  S. Katz Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. , 2006, Reviews in gastroenterological disorders.

[167]  S. Bengmark Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[168]  Stig Bengmark,et al.  Curcumin, An Atoxic Antioxidant and Natural NFκB, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[169]  D. Fuchs,et al.  Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro , 2005, Clinical chemistry and laboratory medicine.

[170]  V. Annese,et al.  Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. , 2005, World journal of gastroenterology.

[171]  Yan Zhu,et al.  Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. , 2005, European journal of immunology.

[172]  Y. Yamori,et al.  Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. , 2004, The Journal of nutrition.

[173]  Andy H. Lee,et al.  Protective effect of green tea against prostate cancer: A case‐control study in southeast China , 2004, International journal of cancer.

[174]  J. Docherty,et al.  Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. , 2004, Antiviral research.

[175]  V. Adhami,et al.  Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. , 2003, Toxicology and applied pharmacology.

[176]  S. Pandol,et al.  Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[177]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.

[178]  V. Raia,et al.  Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[179]  R. Repges,et al.  [Therapy of active Crohn disease with Boswellia serrata extract H 15]. , 2001, Zeitschrift fur Gastroenterologie.

[180]  H. Vogelsang,et al.  Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15 , 2001 .

[181]  M. Suganuma,et al.  Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. , 2000, BioFactors.

[182]  R. Sartor,et al.  Probiotics and inflammatory bowel diseases. , 2000, The American journal of gastroenterology.

[183]  R. Lüdtke,et al.  Effects of Boswellia serrata gum resin in patients with ulcerative colitis. , 1997, European journal of medical research.

[184]  W. Fleig,et al.  Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). , 1996, Scandinavian journal of gastroenterology.

[185]  A. Sonnenberg,et al.  Geographic variation of inflammatory bowel disease within the United States. , 1991, Gastroenterology.